Aurinia Pharmaceuticals (AUPH) Research & Development: 2018-2025
Historic Research & Development for Aurinia Pharmaceuticals (AUPH) over the last 6 years, with Sep 2025 value amounting to $8.4 million.
- Aurinia Pharmaceuticals' Research & Development rose 176.83% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.7 million, marking a year-over-year increase of 29.73%. This contributed to the annual value of $20.8 million for FY2024, which is 58.13% down from last year.
- As of Q3 2025, Aurinia Pharmaceuticals' Research & Development stood at $8.4 million, which was up 13.50% from $7.4 million recorded in Q2 2025.
- Aurinia Pharmaceuticals' Research & Development's 5-year high stood at $20.1 million during Q3 2021, with a 5-year trough of $3.0 million in Q3 2024.
- Moreover, its 3-year median value for Research & Development was $8.1 million (2024), whereas its average is $8.4 million.
- In the last 5 years, Aurinia Pharmaceuticals' Research & Development soared by 228.95% in 2023 and then slumped by 77.60% in 2024.
- Quarterly analysis of 5 years shows Aurinia Pharmaceuticals' Research & Development stood at $11.1 million in 2021, then declined by 11.47% to $9.9 million in 2022, then grew by 3.63% to $10.2 million in 2023, then fell by 20.74% to $8.1 million in 2024, then spiked by 176.83% to $8.4 million in 2025.
- Its Research & Development stands at $8.4 million for Q3 2025, versus $7.4 million for Q2 2025 and $5.7 million for Q1 2025.